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Abstract: Cadmium (Cd) is frequently used in various industrial applications and is a ubiquitous environmental
toxicant, also present in tobacco smoke. An important route of exposure is the circulatory system whereas blood
vessels are considered to be main stream organs of Cd toxicity. Our previous results indicate that cadmium chloride
(CdCl2) affects mean arterial blood pressure in hypertensive rats. We hypothesized that Cd alters the intracellular
calcium transient mechanism, by cadmium-induced stimulation of MAPKs (ERK 1 & 2) which is mediated partially
through calcium-dependent PKC mechanism. To investigate this hypothesis, we exposed primary cultures of vascular
smooth muscle cells (VSMCs) from wistar kyoto (WKY) and spontaneously hypertensive rats (SHR) to increased
concentrations of CdCl2 on cell viability, expression of mitogen-activated protein kinases (MAPKs/ERK 1 & 2), and
protein kinase C (PKC) which are activated by Cd in several cell types. The results from these studies indicate that
CdCl2 decreased cell viability of both SHR and WKY VSMCs in a concentration dependent-manner. Viability of both
cell types decreased 33±5.3 (SHR) and 39±2.3% (WKY) when exposed to 1 µM CdCl2, whereas, 8 and 16 µM
reduced viability by 66±3.1 and 62±4.5% in SHR cells. CdCl2 increased ERK 1 & 2 in a biphasic manner with
maximum increase occurring when cells are exposed to 1 and 4 µM in SHR VSMCs, whereas, a reduction in ERK 1
and 2 is observed when WKY cells are treated with 2 µM. The results also indicate that CdCl2 increased PKC a/ß in
both SHR and WKY VSMCs with a greater increase in expression in SHR VSMCs. In addition, the [Ca2+]i chelator,
BAPTA, suppressed the CdCl2 effect, whereas, the PKC inhibitor, GF109203X, reduced the CdCl2 induced-effect on
PKC expression. The present studies support the hypothesis that Cd can be a risk factor of hypertension through
dysfunction of vascular smooth muscle cells under certain conditions.
Keywords: Protein kinase C; mitogen-activated protein kinase; ERK 1; ERK 2; vascular smooth muscle cells.

Introduction
Cd is frequently used in various industrial activities
and is a ubiquitous environmental toxicant, also present
in tobacco smoke. An important route of exposure is the
circulatory system whereas blood vessels are considered
to be main stream organs of Cd toxicity. Cd exposure via
the respiratory system has been studied [1] and it has
been reported that Cd causes apoptosis in various cell
types in vitro [2]. We have shown that CdCl2 increases
blood pressure in both SHR and WKY rats and chronic
exposure of VSMCs of rats with CdCl2 leads to apoptosis
(unpublished results). However, the mechanism involved
© 2006 MDPI. All rights reserved.

in the elevation of blood pressure and the apoptotic effects
of CdCl2 has not been determined.
The evidence indicates that the mitogen-activated
protein kinase (MAPK) cascade is involved in the
regulation of cell growth, differentiation, and various
cellular stress responses which is mediated through
intracellular signal transduction in response to a variety of
stimuli [3, 4]. More recently, MAPK has been studied in
response to other stresses [5-7] to gain an understanding of
the MAPK signaling mechanisms, specifically, in
cardiovascular disorders [8, 9].
Also, the cellular mechanisms involved in triggering
and development of atherosclerosis induced by Cd may
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include MAPKs and other signal transduction systems,
such as protein kinase C (PKC). Since the discovery that
PKC is the high affinity intracellular receptor of phorbol
esters, it is widely accepted that PKC plays a role in the
regulation of proliferation and differentiation [10, 11].
As these processes involve nuclear regulatory control, it
is thought that PKC must be involved in mediating
nuclear responses to both mitogenic and differentiation
factors [12, 13]. In fact, substantial evidence indicates a
direct role for PKC in linking cell membrane receptor
binding events to responses at the genome level.
It is our hypothesis that CdCl2 alters the calcium
transient
mechanism
through
cadmium-induced
stimulation of MAPK (ERK 1 & 2) which is mediated
partially through calcium-dependent PKC mechanism. In
this study we are providing evidence to support this
hypothesis by reporting the results of specific MAPKs
and PKC-a/ß activation following stimulation with
CdCl2 in VSMCs from a hypertensive phenotype. The
results indicate that ERK 1 and 2 along with PKC-a/ß
are reduced or inhibited within 5 min of stimulation in
SHR cells which may be the results of Cd competing
with intercellular calcium ([Ca2+]i) in activation of the
pathways for these intermediates.
Materials and Methods
Materials
Dulbecco’s Modified Eagle’s medium was obtained
from Cambrex BioScience (Walkersville, MD), fetal
bovine serum, and penicillin/streptomycin, both
purchased from Biowhittaker (Walkersville, MD). For
experimental procedures, CdCl2 was obtained from
Sigma Chemical Company (St. Louis, MO) along with
the calcium chelator, BAPTA-AM. The PKC inhibitor,
GF109203X, was purchased from Tocris (Ballwin, MO).
SDS-Polyacrlymide gels (precast) were ordered from
BioRad Laboratories (Hercules, CA) and nitrocellulose
membrane from Amersham Biosciences (Piscataway,
NJ). Primary antibodies for MAPK and Protein Kinase
C-a/ß were ordered from Cell Signaling (Beverly, MA)
and used for western blotting analysis. To detect and
image the primary MAPK and PKC primary antibodies,
Anti-rabbit IgG secondary antibodies (horseradish
peroxidase linked) was obtained from Amersham
Bioscience (Piscataway, NJ) and chemiluminescent
(ECL) detection system was obtained from Pierce
Biotechnology (Rockford, IL).
Cell Culture and Treatment
Vascular smooth muscle cells were obtained from
Dr. Evangeline Motley (Meharry Medical College) and
cultured in DMEM containing 10% fetal calf serum,
penicillin, and streptomycin. Sub-cultured VSMCs from
passages 3-12, used in the experiments, were seeded into
conventional plastic tissue culture plates (Falcon) and
cultured in DMEM containing 10% fetal calf serum in a

humidified atmosphere of 5% CO2 and O2. CdCl2 was
prepared in DMEM at 50 mM just before application. After
cells were confluent, cells were incubated for the desired
time periods with desired concentrations of CdCl2.
Western Blot Analysis of MAPK and PKC Expression
Cells grown in 6 well plates were stimulated in the
presence or absence of the desired concentrations of CdCl2
at 37ºC for specified durations. The reactions were
terminated by the replacement of medium with 100 µl of
SDS-polyacrylamide gel electrophoresis buffer, pH 6.8,
containing 62.5 mM Tris-HCl, 2% SDS, 10% glycerol, 50
mM dithiothreitol, and 0.1% bromophenol blue. Samples
were sonicated briefly, followed by a one minute flash
spin. Samples were then boiled for three min and
centrifuged at 10,000 RPM for 5 min and supernatant (20
µg) was subjected to a 10% SDS-polyacrylamide gel.
Proteins in the gel were transferred to a nitrocellulose
membrane using the semi-dry transfer method. The
membrane was then blocked for non-specific binding for
one hr with 5% non-fat dry milk. Primary antibodies
specific for ERK 1 & 2 and PKC-a/ß were gently rocked at
4ºC over the membrane overnight and washed before the
membrane was submerged in the secondary antibody for
one hr. After washing, the membrane was incubated with
secondary anti-rabbit antibodies and immunoreactive
proteins were detected by the ECL.
Cell Viability
VSMCs viability was assessed by using trypan blue
exclusion. Briefly, the cells were plated in wells of 6 –well
cluster plate and grown to confluence for 48 hr. After
treatment with CdCl2, the cells were harvested by trypsin
digestion, centrifuged at 1200 x g for 10 min at 4ºC, and
examined by adding an equivalent volume of a 0.4%
trypan blue solution to an aliquot of the re-suspended cells.
The re-suspended cells were incubated for 5 min and the
stained and unstained cells were counted by means of a
hemocytometer.
Statistics
Each experiment was repeated at least 3 times. The
effects of cadmium or antagonists on MAPK and PKC
expression were plotted using a statistic program, prism
(GraphPad Software, San Diego, CA). We performed
densitometric analysis of images from Western blotting
with a molecular imaging system (BioRad). The results are
the mean±SEM and compared by ANOVA of Student-t test
where appropriate. A value of p<0.05 was considered
significant.
Results
The effects of CdCl2 on VSMCs viability are shown in
figure 1. CdCl2 (1-16 µM) exposure of SHR and WKY
VSMCs for 24 hr resulted in a statistically significant
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concentration-related decrease in cell viability for both
cell types. VSMCs viability for both cell types decreased
33 and 39%, respectively, when cells were treated with 1
µM of CdCl2. A significant decrease in cell viability was
observed between the two cell types of 6%. Maximum
decreases in cell viability observed after cells were
treated with concentrations of CdCl2 (8 and 16 µM) were
66±3.1 and 62±4.5% for SHR cells. This decrease in cell
viability was observed to be significantly higher in WKY
cell types, 63±1.5 and 75±5.0%, respectively.

A: CdCl2 effect on MAPK expression of SHR VSMCs

A: CdCl2 effect on cell viability of SHR VSMCs

B: CdCl2 effect on MAPK expression of WKY VSMCs

B: CdCl2 effect on cell viability of WKY VSMCs
Figure 1: Effect of CdCl2 on Cell viability of SHR and
WKY vascular smooth muscle cells. Cell viability was
assessed following incubation of cells with CdCl2 for 24
hr using the trypan blue exclusion method. The mean
levels of cell viability for treating cells with 1-16 µM of
CdCl2 on SHR VSMCs (A) were 66.6±10.5, 44.0±12.8,
33.7±2.6, and 37.5±6.8% and WKY VSMCs (B) were
61±13.5, 45.5±5.9, 36.3±2.7, and 25.3±9.5%,
respectively. The data are the mean± SEM of 3 different
experiments. *Significantly different from time-matched
control, p<0.05.

Figure 2: A concentration dependent effect of CdCl2 on
expression of ERK 1 & 2 in VSMCs of (A) SHR and (B)
WKY rats. VSMCs were stimulated with 1-16 µM of
CdCl2. Cell were harvested in lysis buffer as described in
Material and Methods, and equal protein concentrations (20
µg) were analyzed on a 10% polyacrylamide gel and
transferred to a nitrocellulose membrane. ERK 1 & 2 were
determined by measuring specific phosphorylated ERK 1 &
2 (pp44 ERK-1 and pp42 ERK-2) by western blot.
Densitometric analysis of western blots was done to quantify
the magnitude of change in phosphorylation of MAPKs
induced by CdCl2. Bar graph represents intensities of ERK 1
& 2 bands. The data are the mean± SEM of 3 to 4 different
experiments. *p<0.05 compared to time-matched control.
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We also investigated the effect of CdCl2 on
expression of ERK 1 and 2. The results indicated that
CdCl2 activated ERK 1 and 2 in a biphasic manner in
VSMCs of SHR. Maximum activation of ERK 1 and 2
was observed with 1 and 4 µM of CdCl2 with 8 µM
having similar effects on MAPK expression as that was
observed with 4 µM. Expression of ERK 1 and 2
increased 80±3.6 and 85±4.2%, respectively, of control
and was suppressed with 2 and 16 µM of CdCl2 shown in
figure 2A. Treating WKY VSMCs with similar
concentrations of CdCl2, expression of ERK 1 and 2 was
initially reduced with 2 µM, whereas, 4 µM increased
expression by 77±5.1% of control shown in figure 2B. It
was also observed that 16 µM reduced expression of
ERK 1 and 2 in a similar manner as that observed when
VSMCs of SHR were treated with similar concentrations
of CdCl2.
The time of activation of ERK 1 and 2 in VSMCs
with 4 µM CdCl2 is shown in figure 3A and 3B. The
expression of ERK 1 and 2 was suppressed for the first 2
min in SHR VSMCs. Five (5) min of exposure seem to
reduce expression which was followed by a timedependent increase in expression at 15 min in SHR
VSMCs shown in figure 3A. This increase remained
present up to 60 min of exposure, whereas, the
expression of ERK 1 and 2 increased dramatically within
5 min after exposing WKY VSMCs to CdCl2. Maximum
expression of ERK 1 and 2 in WKY cells was observed
within 5 min of exposure followed by a reduction in
ERK 2 for 10-60 min shown in figure 3B.

A: Time Course on the effect of CdCl2 on ERK 1 & 2
Expression in SHR

B: Time Course on the effect of CdCl2 on ERK 1 & 2
Expression in WKY
Figure 3: A time course effect of CdCl2 on expression
of ERK 1 & 2 in VSMCs of (A) SHR and (B) WKY rats.
VSMCs were stimulated with 4 µM of CdCl2 for the
specified time 1-60 min. Cell were harvested in lysis
buffer as described in Material and Methods, and equal
protein concentrations (20 µg) for each sample were
analyzed on a 10% polyacrylamide gel and transferred to
a nitrocellulose membrane. ERK 1 & 2 were determined
by measuring specific phosphorylated ERK 1 & 2 (pp44
ERK-1 and pp42 ERK-2) by western blot.
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Next, we examined the effect of CdCl2 on PKC
expression in both SHR and WKY VSMCs shown in figure
4A and 4B. CdCl2 increased PKC–a/ß expression in a
concentration and time dependent manner with maximum
expression observed within 15 min of exposing SHR cells
to 4 µM, whereas, maximum expression of PKC- a/ß was
obtained in WKY cells when cells were exposed 30 min or
longer. We also investigated whether the [Ca2+]i and PKC
pathway are link to the CdCl2 effect observed in SHR cells.
GF109203X, the PKC inhibitor, reduced the CdCl2
induced-effect by 32±2.5% whereas BAPTA suppressed
the CdCl2 effect which is shown in figure 5.

A: Time Course on the effect of CdCl2 on PKC Expression
in SHR

B: Time Course on the effect of CdCl2 on PKC Expression
in WKY
Figure 4: A time-dependent effect of CdCl2 on expression of
PKC in VSMCs of SHR (A) and WKY (B). Cells were
stimulated with 4 µM of CdCl2 for 1-60 min. Cells were
harvested in lysis buffer as described in Material and Methods,
and equal protein concentrations (20 µg) were analyzed on a
10% polyacrylamide gel and transferred to a nitrocellulose
membrane. PKC-a/ß expression was determined by measuring
specific phosphorylated PKC-a/ß by western blot.
The antagonistic effects of various antagonists on CdCl2
induced PKC Expression

Figure 5: The antagonistic actions of GF109203X (GF) and
BAPTA on CdCl2 induced stimulation of PKC-a/ßII
expression in SHR VSMCs. Cells were stimulated with 4 µM
of CdCl2 for 5 min following treatment for 1 hr with each
antagonist. PKC-a/ß expression was determined by measuring
specific phosphorylated PKC-a/ß by western blot.
Densitometric analysis of western blots was done to quantify
the magnitude of change in phosphorylation of MAPKs
induced by CdCl2. Bar graph represents intensities of MAPK
bands. The data are the mean± SEM of 3 to 4 different
experiments. *p<0.05 compared to time-matched control.
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Discussion
It has also been shown that Cd exposure rapidly
increases inositol 1, 4, 5,-triphophate and then triggers
Ca2+ mobilization in various cell types [14, 15]. Also, it
has been shown that pre-treatment with an intracellular
Ca2+ chelator, BAPTA/AM, suppresses CdCl2 induced
MAPKs in renal epithelial and CCRF-CEM cells [16]. In
the present study, we examined the effect of CdCl2 on
MAPK and PKC expression in VSMCs of SHR. The
results indicate that CdCl2 decreased cell viability of
both SHR and WKY cells in a concentration dependent
manner. Furthermore, it appears that CdCl2 activates
ERK 1 & 2 in a biphasic manner in SHR VSMCs and
that PKC a/ß expression is more sensitive to CdCl2
effects than what was observed in WKY VSMCs. Also,
CdCl2 induced effect is suppressed with the intracellular
Ca2+ chelator, BAPTA and is reduced significantly with
the PKC inhibitor, GF109203X which may indicate that
the mediated effect of Cd is link to the mobilization of
calcium through the MAPK and PKC pathways which
share a role in the proprogating of the signal generated
by Cd.
It is also known that MAPKs mediate intracellular
signal transduction in response to a variety of stimuli
[3,4]. The MAPK family members are themselves
activated by reverse dual phosphorylation on the Thr and
Tyr residues in the catalytic domain. Three major
MAPKs have been identified, the extra cellular signalregulated kinases (ERK1 and 2), the stress-activated
protein kinases c-Jun NH2-terminal kinases (JNK) and
p38 mitogen activated protein kinases. It seems that Cd
exposure rapidly increases inositol 1, 4, 5,-triphosphate
and then triggers Ca2+ mobilization in various cell types
[14, 15] and that pre-treatment with an intracellular Ca2+
chelator, BAPTA, suppresses CdCl2-induced JNK. The
results from these studies showed that intracellular Ca2+
plays a role in CdCl2-induced activation of ERK, JNK,
and 38 MAPK in CCRF-CEM cells [17].
We previously observed that in hypertensive rat, Cd
increased blood pressure and heart rate. Also Cd
exposure has been implicated in Hypertension and
atherosclerotic lesion [18, 19]. The frequencies of ten
diseases in a Cd-contaminated region in the Netherlands
[20] were investigated and it was found that a
significantly higher frequency for atherosclerosis
occurred which indicated a relationship between Cd
exposure and cardiovascular disease epidemiologically
[21] and in Cd exposed pigeons, not only hypertension
but also atherosclerotic lesion was observed [18].
In conclusion, it was found that Cd can decrease cell
viability and can activate MAPKs and PKC expression in
SHR VSMCs. An intracellular calcium-dependent
pathway is suggested to be involved in the Cd mediated
effect which may lead to its contribution to hypertension
through the dysfunction of VSMCs.
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